APNmAb005
APNmAb005 is a human monoclonal antibody (mAb) targeting MAPT/Tau/PHF-tau. APNmAb005 blocks tau seeding in vitro and rescues neuronal loss in rTG4510 mice. APNmAb005 can be used in Alzheimer’s disease (AD) research[1].
Product Specifications
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
Tau Protein
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Purity
97.64
Smiles
[APNmAb005]
Molecular Weight
(145.92 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]Tai C Y, et al. APNmAb005, an anti‐tau antibody targeting synaptic tau oligomers, in Phase 1 for treatment of Alzheimer’s Disease and primary tauopathies[J]. Alzheimer's & Dementia, 2023, 19: e076888.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6307975-01 0.1 mL
HOXC10, ID (HOXC10, HOX3I, Homeobox protein Hox-C10, Homeobox protein Hox-3I) (MaxLight 550)
Sign In for Pricing
View Details MBS6307975-02 5x 0.1 mL
HOXC10, ID (HOXC10, HOX3I, Homeobox protein Hox-C10, Homeobox protein Hox-3I) (MaxLight 550)
Sign In for Pricing
View Details